Dr. Ed Jackson is a senior experienced clinical pharmacologist in renal and cardiovascular pharmacology. He is Associate Director of the Center for Clinical Pharmacology and directs its laboratory resources in genetics, mass spectrometry, cell culture and animal physiology. His very highly active research program networks within the institution and between multiple institutions.
- BS, University of Texas at Austin, College of Pharmacy, 1976
- PhD, Pharmacology, University of Texas, 1979
- Postdoctoral Fellowship, Clinical Pharmacology, Vanderbilt University, 1983
Education & Training
Dubey, R.K., Fingerle, J., Gillespie, D.G., Mi,Z., Rosselli, M., Imthum, B., Jackson, E.K. Adenosine Attenuates Human Coronary Artery Smooth Muscle Cell Proliferation by Inhibiting Multiple Signaling Pathways That Converge on Cyclin D. Hypertension. 2015; 66(6): 1207-19.
Rigassi, L., Barchiesi Bozzolo, F., Lucchinetti, E., Zaugg, M., Fingerle, J., Rosselli, M., Imthum, B., Jackson, E.K., Dubey, R.K. 2-Methoxyestradiol blocks the RhoA/ROCK1 pathway in human aortic smooth muscle cells. American Journal of Physiology - Endocrinology and Metabolism. 2015; 309(12): E995-1007.
Jackson, E.K., Menshikova, E.V., Mi, Z., Verrier, J.D., Bansal, R., Janesko-Feldman, K., Jackson T.C., Kochanek, P.M. Renal 2',3'-Cyclic Nucleotide 3'-Phosphodiesterase Is an Important Determinant of AKI Severity after Ischemia-Reperfusion. Journal of the American Society of Nephrology. 2016; 27(7): 2069-81.
Tofovic, S.P., Salah, E.M., Smits, G.J., Whalley, E.T., Ticho, B., Deykin, A., Jackson, E.K. Dual A1/A2B Receptor Blockade Improves Cardiac and Renal Outcomes in a Rat Model of Heart Failure with Preserved Ejection Fraction. Journal of Pharmacology and Experimental Therapeutics. 2016; 356(2): 333-40.
Jackson, E.K. Discovery and Roles of 2',3'-cAMP in Biological Systems. Handbook of Experimental Pharmacology. 2016
Schaufelberger, S.A., Rosselli, M., Barchiesi, F., Gillespie, D.G., Jackson, E.K., Dubey, R.K. 2-Methoxyestradiol, an endogenous 17ß-estradiol metabolite, inhibits microglial proliferation and activation via an estrogen receptor-independent mechanism. American Journal of Physiology - Endocrinology and Metabolism. 2016; 310(5): E313-22.
Jackson, E.K., Boison, D., Schwarzchild, M.A., Kochanek, P.M. Purines: forgotten mediators in traumatic brain injury. Journal of Neurochemistry. 2016; 137(2): 142-53.
Schuler, P.J., Westerkamp, A.M., Kansy, B.A., Bruderek, K., Dissmann, P.A., Dumitru, C.A., Lang, S., Jackson, E.K., Brandau, S. Adenosine metabolism of human mesenchymal stromal cells isolated from patients with head and neck squamous cell carcinoma. Immunobiology. 2016
Figueiro, F., Muller, L., Funk, S., Jackson, E.K., Battastini, A.M., Whiteside, T.L. Phenotypic and functional characteristics of CD39high human regulatory B cells (Breg). Oncoimmunology. 2016; 5(2): e1082703.
Tofovic, S.P., Jackson, E.K. Estrogens in Men: Another Layer of Complexity of Estradiol Metabolism in Pulmonary Hypertension. American Journal for Respiratory Critical Care. 2016; 193(10): 1087-90.
